| Ytd | -39.04% | |
| 1y | -9.52% |
| Open | 1.17 | Prev Close | 1.15 | Low | 1.14 | High | 1.17 | Mkt Cap | 354.09M |
| Vol | 6.10M | Avg Vol | 6.45M | EPS | -0.41 | P/E | -2.78 | Forward P/E | -2.84 |
| Beta | 2.01 | Short Ratio | 4.46 | Inst. Own | 84.53% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 1.45 | 200-d Avg | 1.69 | 1yr Est | 3.02 |
PACB News
PACB cuts its 2026 revenue outlook after Q2 sales fall 2%, as consumables and EMEA growth fail to of
Pacific Biosciences reported Q2 revenues of $39.01 million, missing estimates and guiding 2026 reven
Pacific Biosciences of California, Inc. (PACB) Q2 2026 Earnings Call Transcript
Pacific Biosciences of California NASDAQ: PACB reported second-quarter 2026 revenue of $39 million,
On July 30, 2026, the Board of Directors (the "Board") of the Company approved a restructuri
Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.14 per share in line w
Pacific Biosciences (NASDAQ:PACB) lowers FY2026 sales outlook from $165.000 million-$175.000 million
Pacific Biosciences of California, Inc. (NASDAQ: PACB) ("PacBio"), a leading developer of hi
Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.14) per share which missed the an
MENLO PARK, Calif. , Aug. 05, 2026 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASD
MENLO PARK, Calif. , Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financi
Vega SPRQ-Nx chemistry to deliver up to 90 Gb per run at 40% lower cost per gigabase, with single-sh
McKesson, Cencora, Solventum and PacBio head into earnings with resilient demand offset by tariffs,
Pacific Biosciences of California, Inc. (NASDAQ: PACB - Get Free Report) has been assigned a consens
Pacific Biosciences of California (PACB) reached $1.39 at the closing of the latest trading day, ref
MENLO PARK, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of
Amova Asset Management Americas Inc. cut its position in shares of Pacific Biosciences of California
In the most recent trading session, Pacific Biosciences of California (PACB) closed at $1.36, indica
MENLO PARK, Calif. , July 15, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it
Pacific Biosciences of California (PACB) concluded the recent trading session at $1.49, signifying a
PACB's growth is supported by HiFi sequencing advances and product momentum, though funding pressure
On Wednesday, June 10, 2026, Ark Invest sold $7.8M in Robinhood shares Wednesday while adding 141,50
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earning
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for it
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimat
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fisc
Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quar
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Fri
Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The compan
Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatil
Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report qua
On Tuesday, 951 companies hit new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.
On Friday, 422 stocks made new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.